Gilead Sciences Inc (NASDAQ: GILD)

DRUGS - Biotechnology
Sector: Health Care

Stock price data as of 04/19/2024

Closing price: 66.76

Support price level:	N/A
Resistance price level:	$72.57
Relative strength index (14-day RSI)	17.7
Beta	0.30

GILD is at or near its 52-week low. Though contrarian gains may be possible, the risk of further declines is considerable.
With a -20.6 percent return in the past year, this stock is among the worst 10 percent of performers in the S&P-100.
The price of this low-beta stock is expected to increase by 0.30% for every 1% increase in the S&P-500.
GILD is one of this week's least volatile stocks in the S&P-100 with an estimated annualized standard deviation of 16.4%.
Volatility is forecast to fall over the next month.
With RSI < 30, GILD is oversold. Odds slightly favor a short-term price reversal.
Price broke below prior support level - a short-term bearish signal.

Low	High	Price as % of Range
$66.16	$87.29	3.3%

200 day	50 day	20 day	10 day
$76.60	$72.01	$69.90	$67.91

(Annualized standard deviation)

Historical (5 year)	Last month	Current estimate	Next month forecast
25.7%	22.1%	16.4%	20.6%

There is an estimated 5% probability that the stock price of Gilead Sciences Inc will fall by more than: